Details
Stereochemistry | RACEMIC |
Molecular Formula | C17H15NO3 |
Molecular Weight | 281.3059 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C(O)=O)C1=CC=C(C=C1)N2CC3=CC=CC=C3C2=O
InChI
InChIKey=RJMIEHBSYVWVIN-UHFFFAOYSA-N
InChI=1S/C17H15NO3/c1-11(17(20)21)12-6-8-14(9-7-12)18-10-13-4-2-3-5-15(13)16(18)19/h2-9,11H,10H2,1H3,(H,20,21)
Molecular Formula | C17H15NO3 |
Molecular Weight | 281.3059 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Indoprofen is one of several NSAIDs that have been withdrawn from the market due to causing severe gastrointestinal bleeding. The UK Licensing Authority suspended the product license on grounds of safety in 1983 and in 1984 the Italian manufacturers decided to withdraw it from the world market. The UK decision was taken because there was a high rate of adverse drug reactions in a voluntary postmarketing surveillance study and the spontaneous adverse reaction reporting system had noted 217 serious adverse effects, mainly gastrointestinal bleeding and perforation.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1075189 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26951145 |
21.0 µM [IC50] | ||
Target ID: CHEMBL2094253 |
|||
Target ID: CHEMBL5738 Sources: http://drugcentral.org/drugcard/1442 |
1.27 µM [Ki] |
PubMed
Title | Date | PubMed |
---|---|---|
The non-steroidal anti-inflammatory drug, indomethacin, as an inhibitor of HIV replication. | 1995 Feb 20 |
|
Retrospective analysis of drug-induced urticaria and angioedema: a survey of 2287 patients. | 2001 Nov |
|
A three-component coupling process based on vicarious nucleophilic substitution (VNS(AR))-alkylation reactions: an approach to indoprofen and derivatives. | 2002 Jan 25 |
|
Optimization of sample stacking for the simultaneous determination of nonsteroidal anti-inflammatory drugs with a wall-coated histidine capillary column. | 2004 Feb |
|
DNA photosensitization by indoprofen - is DNA damage photoinduced by indoprofen or by its photoproducts? | 2004 Feb |
|
Investigating the potential of erythromycin and derivatives as chiral selector in capillary electrophoresis. | 2004 Mar 10 |
|
Effect of anti-inflammatory drugs on splenocyte membrane fluidity. | 2005 Apr 1 |
|
Comparative study of the photophysical properties of indoprofen photoproducts in relation with their DNA photosensitizing properties. | 2005 Mar |
|
Modification of pepsinogen I levels and their correlation with gastrointestinal injury after administration of dexibuprofen, ibuprofen or diclofenac: a randomized, open-label, controlled clinical trial. | 2006 Apr |
|
Chiral ionic liquids for enantioseparation of pharmaceutical products by capillary electrophoresis. | 2008 Sep 19 |
|
Enantiomeric separation of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs by HPLC with hydroxypropyl-beta-cyclodextrin as chiral mobile phase additive. | 2010 Aug |
|
Spinal muscular atrophy disease: a literature review for therapeutic strategies. | 2010 Jan-Mar |
|
Discovery, synthesis, and biological evaluation of novel SMN protein modulators. | 2011 Sep 22 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:25:18 GMT 2023
by
admin
on
Fri Dec 15 15:25:18 GMT 2023
|
Record UNII |
CPE46ZU14N
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QM01AE10
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
||
|
WHO-ATC |
M01AE10
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
||
|
NCI_THESAURUS |
C257
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000083395
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
PRIMARY | |||
|
3689
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
PRIMARY | |||
|
DTXSID5045831
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
PRIMARY | |||
|
SUB08183MIG
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
PRIMARY | |||
|
m771
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
PRIMARY | Merck Index | ||
|
31842-01-0
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
PRIMARY | |||
|
C83801
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
PRIMARY | |||
|
53022-60-9
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
SUPERSEDED | |||
|
757065
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
PRIMARY | |||
|
3718
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
PRIMARY | |||
|
250-833-0
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
PRIMARY | |||
|
CPE46ZU14N
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
PRIMARY | |||
|
1442
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
PRIMARY | |||
|
CHEMBL15870
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
PRIMARY | |||
|
D007216
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
PRIMARY | |||
|
76162
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
PRIMARY | |||
|
INDOPROFEN
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
PRIMARY | |||
|
DB08951
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |